Sudeep Pharma Q2 revenue rises 21%, profit up 11%
SUDEEPPHRM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q2 FY27 consolidated revenue rose 20.9% year on year to Rs 19,669.91 lakh and profit rose 10.8% to Rs 5,181.11 lakh. April-September revenue rose 23.4% to Rs 35,496.96 lakh and profit rose 18.4% to Rs 9,239.80 lakh. Pharma, food and nutrition revenue grew 57.5%, while specialty ingredients fell 24.9%. Operating cash flow was positive at Rs 4,350.31 lakh. One subsidiary was not reviewed, but its results were stated to be immaterial.
Strong group sales, profit and cash flow support sentiment, but uneven segment growth and a 25% fall in specialty ingredients revenue are concerns.